Prodrugs activated by targeted catalytic proteins

Catalytic antibodies are disclosed. The catalytic antibodies are specific for prodrug compounds. The catalytic antibodies enhance cleavage of an active drug moiety from a prodrug residue, thereby activating the drug.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SMITH RODGER, KAMIREDDY BALREDDY, TITMAS RICHARD C, MARTIN MARK T, WILLIAMS RICHARD O, CASADEI JAN M, SIMPSON DAVID M, MASSEY RICHARD J, NAPPER ANDREW D, VON BORSTEL REID, KENTEN JOHN
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Catalytic antibodies are disclosed. The catalytic antibodies are specific for prodrug compounds. The catalytic antibodies enhance cleavage of an active drug moiety from a prodrug residue, thereby activating the drug.